SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp (BULL) is seeing heightened volatility and intense social media discussion as traders speculate on potential earnings leaks and manipulation ahead of the company's latest quarterly report. The community remains deeply divided, with bulls pointing toward the firm's growth in customer assets and upcoming regulatory changes as long-term catalysts, while bears focus on rising operating expenses and persistent downward pressure on the share price.

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.

Akari Therapeutics Plc - ADR

Akari Therapeutics

Akari Therapeutics is trending as the stock surges following positive preclinical data for its lead ADC candidate and continued momentum from its recent strategic merger. The community is actively discussing the stock's low float and the potential for a short squeeze as investors weigh the impact of new leadership against the company's history of significant valuation declines.

UP Fintech Holding Ltd. is an online brokerage firm that focuses on global investors. It provides an online trading platform that enables investors to trade in equities and other financial instruments on multiple exchanges around the world. The firm offers products and services, as well as a user experience to customers through its mobile first strategy. The company was founded by Tian Hua Wu in June 2014 and is headquartered in Singapore.

UP Fintech Holding Ltd - ADR

UP Fintech is facing significant volatility as investors react to potential regulatory penalties in China, fueling concerns about the stability of the company's overseas brokerage operations. While some traders view the resulting pullback as a buying opportunity given the company's strong revenue growth and client account expansion, others are bracing for further downside amid broader skepticism toward Chinese ADRs.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor Corp. is capturing significant market attention as investors weigh the company's strong brand performance from HOKA and UGG against concerns over supply chain headwinds and institutional downgrades. While community sentiment remains divided between bulls focused on solid revenue growth and buyback initiatives and bears concerned about weakening leadership and sector-wide competitive pressure, market participants are bracing for upcoming earnings to provide clarity on the stock's future trajectory.

Futu Holdings Ltd. engages in the provision of digitalized financial services. It offers securities brokerage and wealth management products. The company was founded by Leaf Hua Li in December 2007 and is headquartered in Hong Kong.

Futu Holdings Ltd - ADR

Futu Holdings is trending as shares face heavy downward pressure following reports of a two-year regulatory crackdown in China targeting overseas trading platforms. The community is actively debating whether to buy the dip as a value play or avoid the stock entirely due to persistent geopolitical risks and regulatory uncertainty.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is trending after reporting strong quarterly results that surpassed earnings and revenue expectations, helping to alleviate concerns regarding the durability of enterprise software demand. The community is actively discussing the company's progress in AI integration and whether these results signal a stabilization for the broader software sector against the rising narrative of AI-driven disruption.

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Olema Pharmaceuticals is surging as the success of a competitor's late-stage trial for a similar breast cancer drug class validates the potential of its own pipeline and fuels intense speculation about a future buyout. Community members are actively debating the sustainability of the rally versus risks like dilution, while institutional ownership and the potential for a short squeeze remain key focal points.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. is seeing intense community focus as shareholders monitor a seven-month breakout attempt and significant institutional accumulation, including recent position increases by major asset managers. Traders are actively debating the company's daily dividend strategy and balance sheet expansion while keeping a close watch on potential legislative catalysts and volatility linked to Bitcoin's price action.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is seeing a surge in investor attention as the community identifies a classic short squeeze setup, fueled by high short interest, a shrinking float due to aggressive share buybacks, and anticipation ahead of earnings. Traders are actively discussing the stock's potential for parabolic movement, drawing comparisons to other high-profile squeeze plays while monitoring key technical resistance levels for a potential breakout.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is garnering significant attention as the R2 configurator goes live and customer deliveries approach, signaling a major product milestone for the company. Community sentiment remains polarized, with bulls highlighting the long-term potential of the R2 platform and strategic partnerships, while bears express concern over execution timelines, share dilution, and the stock's recent downward price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029?

PFE targets high single-digit revenue CAGR from 2029 as new launches, acquisitions and pipeline growth may offset LOE headwinds.

Wells Fargo & Company Cuts BioNTech (NASDAQ:BNTX) Price Target to $140.00

Wells Fargo & Company lowered their price target on shares of BioNTech from $150.00 to $140.00 and set an "overweight" rating for the company in a report on Wednesday...

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from Analysts

Shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eighteen research firms that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, four have given a hold re...

Pfizer Beats on Q1 Earnings, New & Acquired Drugs Drive Sales Growth

Pfizer beats Q1 estimates as new launches and acquired drugs lift sales, offsetting COVID declines, while the drugmaker reaffirms its 2026 outlook.

BioNTech Q1 Earnings Call Highlights

BioNTech (NASDAQ:BNTX) executives used the company's first-quarter 2026 earnings call to highlight a strategy centered on combination oncology therapies, provide updates on late-stage clinical...

BioNTech (NASDAQ:BNTX) Announces Earnings Results

BioNTech (NASDAQ:BNTX - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($2.26) earnings per share for the quarter, topping analysts' consensus estimates of...

Mitsubishi UFJ Trust & Banking Corp Sells 92,271 Shares of BioNTech SE Sponsored ADR $BNTX

Mitsubishi UFJ Trust & Banking Corp decreased its position in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 59.8% during the fourth quarter, according to the company in its most recent...

Pictet Asset Management Holding SA Buys 26,119 Shares of BioNTech SE Sponsored ADR $BNTX

Pictet Asset Management Holding SA lifted its stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 41.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 88,838 shares of the company's stock after acquirin...

BioNTech (NASDAQ:BNTX) Shares Gap Down - What's Next?

BioNTech (NASDAQ:BNTX) Shares Gap Down - What's Next...

Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q1 Earnings

Pfizer sees mixed Q1 signals as growth in key drugs offsets COVID declines. Can pipeline strength and M&A bets support long-term upside?

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BNTX
BioNTech SE - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest BNTX News

BNTXBioNTech SE - ADR